Copyright
©The Author(s) 2021.
World J Clin Cases. May 26, 2021; 9(15): 3680-3688
Published online May 26, 2021. doi: 10.12998/wjcc.v9.i15.3680
Published online May 26, 2021. doi: 10.12998/wjcc.v9.i15.3680
Figure 3 Changes in C-reactive protein after oral administration of Roxadustat.
Arrow at week 16, C-reactive protein was significantly elevated in the patient because of concurrent respiratory infections. CRP: C-reactive protein.
- Citation: Fei M, Wen XQ, Yu ZL, Kang T, Wu WH, Ou ST. Roxadustat as treatment for a blood transfusion-dependent maintenance hemodialysis patient: A case report and review of literature. World J Clin Cases 2021; 9(15): 3680-3688
- URL: https://www.wjgnet.com/2307-8960/full/v9/i15/3680.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i15.3680